CN Stock MarketDetailed Quotes

002755 Beijing Aosaikang Pharmaceutical

Watchlist
  • 10.00
  • -0.04-0.40%
Market Closed Jun 14 15:00 CST
9.28BMarket Cap-192307P/E (TTM)

Beijing Aosaikang Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
56.11%1.17B
35.50%1.05B
-1.27%822.59M
-11.13%658.17M
-14.20%747.52M
-33.70%772.71M
-1.55%833.14M
-13.28%740.59M
5.98%871.26M
-14.87%1.17B
Transactional financial assets
-5.22%727.62M
-14.93%713.83M
-1.00%868.41M
-8.99%833.24M
-6.34%767.66M
60.62%839.08M
78.01%877.17M
64.07%915.58M
27.07%819.61M
422.39%522.39M
Notes receivable and accounts receivable
-17.55%139.79M
-33.76%141.32M
-36.86%188.69M
-47.35%183.93M
-56.11%169.54M
-57.04%213.36M
-42.43%298.87M
-42.14%349.31M
-43.35%386.25M
-30.43%496.62M
-Notes receivable
----
----
----
----
----
182.95%2.03M
----
----
--1.98M
--716.18K
-Accounts receivable
-17.55%139.79M
-33.13%141.32M
-36.86%188.69M
-47.35%183.93M
-55.88%169.54M
-57.38%211.33M
-42.43%298.87M
-41.68%349.31M
-43.64%384.27M
-30.53%495.9M
Other receivables (including interest and dividends)
-42.17%13.59M
97.88%49.88M
-38.34%16.47M
13.82%22.96M
41.77%23.49M
54.74%25.21M
-73.86%26.71M
17.97%20.17M
-2.94%16.57M
-34.29%16.29M
-Dividend receivable
----
233.33%1.56M
----
----
----
--467.8K
----
----
----
----
-Other receivable
----
----
----
13.82%22.96M
----
51.87%24.74M
----
17.97%20.17M
----
-34.29%16.29M
Advance payment
-57.88%20.59M
57.15%14.84M
-70.45%15.23M
-90.10%13.56M
-11.45%48.89M
-39.55%9.44M
-77.78%51.54M
198.53%137.01M
30.67%55.21M
45.39%15.62M
Inventories
7.10%170.05M
18.34%167.49M
11.36%156.99M
-3.45%154.45M
13.58%158.78M
-0.22%141.53M
-4.36%140.98M
8.26%159.98M
-12.33%139.8M
-15.94%141.84M
Receivable financing
-45.81%73.62M
-63.60%39.92M
-34.29%54.54M
-38.48%60.88M
13.06%135.85M
28.66%109.67M
-31.30%83M
-18.00%98.96M
-57.10%120.16M
-66.50%85.24M
Other current assets
-60.24%13.11M
-55.16%12.16M
25.94%25.19M
87.62%27M
-24.10%32.98M
-37.69%27.12M
70.03%20M
-14.78%14.39M
356.52%43.45M
725.98%43.52M
Total current assets
11.54%2.33B
2.26%2.19B
-7.86%2.15B
-19.78%1.95B
-14.99%2.08B
-14.03%2.14B
-5.70%2.33B
3.04%2.44B
-7.71%2.45B
-6.04%2.49B
Non Current assets
Other equity investment
260.23%13.67M
259.37%13.69M
262.12%13.99M
14.24%4.03M
9.07%3.79M
14.40%3.81M
5.22%3.86M
-7.97%3.53M
-9.89%3.48M
-16.86%3.33M
Investment real estate
-5.10%39.53M
-5.04%40.06M
3,033.67%40.59M
3,005.48%41.12M
2,978.50%41.65M
2,952.64%42.18M
-8.18%1.3M
-8.02%1.32M
-7.86%1.35M
-7.71%1.38M
Long-term equity investment
-0.30%103.89M
0.73%104.52M
2.70%105M
3.02%104.96M
2.93%104.2M
1.88%103.76M
6.31%102.25M
9.97%101.89M
12.99%101.23M
38.85%101.84M
Fixed assets
----
----
----
-20.30%468.07M
----
-19.00%506.45M
----
-11.09%587.27M
----
-9.50%625.26M
Constru in process
----
----
----
48.46%34.93M
----
51.18%29.8M
----
36.64%23.53M
----
25.36%19.71M
Intangible assets
65.24%156.56M
2.69%98.34M
-1.98%99.69M
-1.93%100.87M
-8.89%94.75M
-1.97%95.77M
21.99%101.71M
22.79%102.86M
23.31%104M
15.04%97.69M
Development expenditure
19.27%503M
27.56%530.41M
30.27%469.28M
30.34%446.36M
37.49%421.72M
34.64%415.81M
28.69%360.23M
29.08%342.45M
20.28%306.73M
31.66%308.84M
Long deferred expense
-13.21%31.84M
-12.79%33.05M
-12.39%34.26M
-12.37%35.47M
15.47%36.68M
14.19%37.89M
13.02%39.1M
12.40%40.48M
41.74%31.77M
44.90%33.18M
Deferred tax assets
2.81%24.38M
-0.48%25.73M
-13.47%26.05M
-15.07%28.92M
-22.01%23.72M
-9.90%25.85M
1.95%30.1M
19.78%34.05M
11.04%30.41M
6.65%28.69M
Usufruct assets
-11.40%8.97M
-27.58%7.89M
-28.95%8.49M
-20.53%9.34M
-22.84%10.12M
-18.43%10.9M
--11.95M
--11.75M
--13.12M
-17.89%13.36M
Other non current assets
189.66%10.72M
227.15%13.2M
15.39%10.8M
30.25%5.25M
-13.78%3.7M
-7.65%4.04M
21.08%9.36M
-26.60%4.03M
-23.57%4.29M
-31.59%4.37M
Total non current assets
8.17%1.36B
4.79%1.34B
3.54%1.29B
2.09%1.28B
2.64%1.26B
3.12%1.28B
4.62%1.25B
4.90%1.25B
3.81%1.23B
5.11%1.24B
Total assets
10.27%3.69B
3.21%3.52B
-3.88%3.44B
-12.35%3.23B
-9.11%3.34B
-8.33%3.41B
-2.33%3.58B
3.66%3.69B
-4.17%3.68B
-2.60%3.72B
Liabilities
Current liabilities
Short term loan
86.59%84.03M
153.18%114.02M
-3.30%29.01M
--59.04M
--45.03M
--45.03M
--30M
----
----
----
Notes payable and accounts payable
24.43%45.53M
-2.01%38.29M
17.79%60.22M
-56.63%34.41M
-59.01%36.59M
-40.54%39.08M
-4.23%51.13M
27.31%79.34M
5.17%89.26M
-31.03%65.72M
-Notes payable
----
----
--30M
----
----
----
----
----
----
----
-Accounts payable
24.43%45.53M
-2.01%38.29M
-40.89%30.22M
-56.63%34.41M
-59.01%36.59M
-40.54%39.08M
-4.23%51.13M
27.31%79.34M
5.17%89.26M
-31.03%65.72M
Contract liabilities
194.82%28.54M
29.95%13.8M
45.12%11.94M
-34.85%10.32M
-30.90%9.68M
-30.39%10.62M
-69.89%8.23M
21.00%15.84M
16.15%14.01M
-51.07%15.26M
Advance receipts
77.76%473.14K
95.05%2.08M
--374.21K
--356K
--266.17K
--1.06M
----
----
----
----
Salaries payable
-30.70%10.71M
-16.51%34.58M
-19.20%15.15M
4.99%15.7M
-0.35%15.45M
-6.84%41.42M
-33.25%18.75M
-35.96%14.96M
-25.42%15.5M
-21.43%44.46M
Taxs payable
8.62%13.94M
-8.28%13.54M
-31.48%21.16M
-58.45%15.91M
-67.76%12.84M
-72.06%14.76M
-37.35%30.88M
-34.39%38.29M
-31.81%39.81M
-28.61%52.83M
Other payable (including interest and dividends)
104.45%380.48M
26.12%210.53M
112.22%369.11M
-9.40%161.35M
7.23%186.1M
-23.73%166.93M
-7.18%173.93M
-14.33%178.1M
-49.64%173.55M
-46.47%218.85M
-Dividend payable
----
----
----
----
----
----
----
--25.65M
----
----
-Other payable
----
----
----
5.84%161.35M
----
-23.73%166.93M
----
-26.67%152.44M
----
-46.47%218.85M
Non current liabilities due within one year
-0.33%3.56M
-12.31%3.03M
3.21%3.2M
17.30%3.45M
53.03%3.57M
32.44%3.45M
--3.1M
--2.94M
--2.34M
3.37%2.61M
Other current liabilities
194.82%3.71M
21.48%1.68M
45.12%1.55M
-55.40%918.13K
-30.90%1.26M
-30.39%1.38M
-69.89%1.07M
21.00%2.06M
-31.63%1.82M
-51.07%1.98M
Total current liabilities
83.72%570.97M
33.30%431.55M
61.38%511.72M
-9.07%301.45M
-7.58%310.78M
-19.41%323.74M
-9.15%317.09M
-9.60%331.52M
-38.11%336.29M
-41.99%401.71M
Current liabilities
Deferred tax liabilities
-18.95%10.18M
-18.95%10.18M
-16.73%12.56M
-12.61%12.9M
-16.73%12.56M
-16.73%12.56M
-4.14%15.08M
-3.60%14.76M
-2.63%15.08M
-2.65%15.08M
Long term deferred income
-5.46%63.73M
15.97%64.72M
30.25%68.6M
16.94%70.54M
-1.31%67.41M
-19.04%55.81M
-23.80%52.67M
-13.78%60.32M
-2.16%68.31M
-0.69%68.93M
Lease liabilities
-21.95%5.92M
-24.27%6.75M
-38.52%5.9M
-19.88%7.94M
-33.54%7.59M
-22.59%8.92M
--9.59M
--9.91M
--11.42M
-16.19%11.52M
Total non current liabilities
-8.83%79.83M
5.65%81.65M
12.56%87.06M
7.52%91.39M
-7.65%87.56M
-19.10%77.29M
-8.85%77.34M
-0.33%85M
11.14%94.81M
-3.16%95.53M
Total liabilities
63.38%650.8M
27.97%513.2M
51.81%598.78M
-5.69%392.83M
-7.60%398.34M
-19.35%401.03M
-9.09%394.43M
-7.85%416.52M
-31.43%431.1M
-37.15%497.24M
Shareholders equity
Paid-in capital
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
0.00%928.16M
Capital reserve funds
165.50%117.45M
169.95%136.94M
9.83%62.73M
-32.81%40.55M
1,742.59%44.24M
5,294.75%50.73M
3,699.98%57.11M
3,944.22%60.35M
60.89%2.4M
-36.99%940.31K
Surplus reserve funds
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
0.00%248.23M
Retained profit
-2.92%1.61B
-8.59%1.58B
-18.14%1.54B
-20.17%1.57B
-19.67%1.66B
-15.56%1.73B
-8.41%1.89B
1.89%1.97B
1.74%2.07B
10.48%2.05B
Other composite income
-67.61%3.51M
-23.30%4.96M
43.33%16.6M
169.29%11.64M
348.17%10.84M
204.97%6.47M
349.44%11.58M
192.04%4.32M
-8.04%-4.37M
-66.38%-6.16M
Specific reserves
37.90%2.09M
107.16%1.62M
78.54%1.91M
231.15%1.74M
1,621.08%1.51M
196.54%781.85K
3.07%1.07M
69.21%526.33K
--88.02K
--263.66K
Shareholders equity without minority interests
0.62%2.91B
-2.13%2.9B
-10.56%2.8B
-12.72%2.8B
-10.74%2.89B
-7.94%2.96B
-3.13%3.13B
3.37%3.21B
1.13%3.24B
6.33%3.22B
Minority interests
140.96%124.62M
119.77%110.7M
-22.86%42.72M
-37.30%40.19M
759.16%51.72M
470.78%50.37M
24,301.31%55.38M
2,200.24%64.1M
35.27%6.02M
45.70%8.82M
Total shareholder equity
3.09%3.04B
-0.09%3.01B
-10.77%2.84B
-13.20%2.84B
-9.31%2.94B
-6.64%3.01B
-1.43%3.19B
5.34%3.27B
1.17%3.25B
6.41%3.23B
Total liabilityies and equity
10.27%3.69B
3.21%3.52B
-3.88%3.44B
-12.35%3.23B
-9.11%3.34B
-8.33%3.41B
-2.33%3.58B
3.66%3.69B
-4.17%3.68B
-2.60%3.72B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 56.11%1.17B35.50%1.05B-1.27%822.59M-11.13%658.17M-14.20%747.52M-33.70%772.71M-1.55%833.14M-13.28%740.59M5.98%871.26M-14.87%1.17B
Transactional financial assets -5.22%727.62M-14.93%713.83M-1.00%868.41M-8.99%833.24M-6.34%767.66M60.62%839.08M78.01%877.17M64.07%915.58M27.07%819.61M422.39%522.39M
Notes receivable and accounts receivable -17.55%139.79M-33.76%141.32M-36.86%188.69M-47.35%183.93M-56.11%169.54M-57.04%213.36M-42.43%298.87M-42.14%349.31M-43.35%386.25M-30.43%496.62M
-Notes receivable --------------------182.95%2.03M----------1.98M--716.18K
-Accounts receivable -17.55%139.79M-33.13%141.32M-36.86%188.69M-47.35%183.93M-55.88%169.54M-57.38%211.33M-42.43%298.87M-41.68%349.31M-43.64%384.27M-30.53%495.9M
Other receivables (including interest and dividends) -42.17%13.59M97.88%49.88M-38.34%16.47M13.82%22.96M41.77%23.49M54.74%25.21M-73.86%26.71M17.97%20.17M-2.94%16.57M-34.29%16.29M
-Dividend receivable ----233.33%1.56M--------------467.8K----------------
-Other receivable ------------13.82%22.96M----51.87%24.74M----17.97%20.17M-----34.29%16.29M
Advance payment -57.88%20.59M57.15%14.84M-70.45%15.23M-90.10%13.56M-11.45%48.89M-39.55%9.44M-77.78%51.54M198.53%137.01M30.67%55.21M45.39%15.62M
Inventories 7.10%170.05M18.34%167.49M11.36%156.99M-3.45%154.45M13.58%158.78M-0.22%141.53M-4.36%140.98M8.26%159.98M-12.33%139.8M-15.94%141.84M
Receivable financing -45.81%73.62M-63.60%39.92M-34.29%54.54M-38.48%60.88M13.06%135.85M28.66%109.67M-31.30%83M-18.00%98.96M-57.10%120.16M-66.50%85.24M
Other current assets -60.24%13.11M-55.16%12.16M25.94%25.19M87.62%27M-24.10%32.98M-37.69%27.12M70.03%20M-14.78%14.39M356.52%43.45M725.98%43.52M
Total current assets 11.54%2.33B2.26%2.19B-7.86%2.15B-19.78%1.95B-14.99%2.08B-14.03%2.14B-5.70%2.33B3.04%2.44B-7.71%2.45B-6.04%2.49B
Non Current assets
Other equity investment 260.23%13.67M259.37%13.69M262.12%13.99M14.24%4.03M9.07%3.79M14.40%3.81M5.22%3.86M-7.97%3.53M-9.89%3.48M-16.86%3.33M
Investment real estate -5.10%39.53M-5.04%40.06M3,033.67%40.59M3,005.48%41.12M2,978.50%41.65M2,952.64%42.18M-8.18%1.3M-8.02%1.32M-7.86%1.35M-7.71%1.38M
Long-term equity investment -0.30%103.89M0.73%104.52M2.70%105M3.02%104.96M2.93%104.2M1.88%103.76M6.31%102.25M9.97%101.89M12.99%101.23M38.85%101.84M
Fixed assets -------------20.30%468.07M-----19.00%506.45M-----11.09%587.27M-----9.50%625.26M
Constru in process ------------48.46%34.93M----51.18%29.8M----36.64%23.53M----25.36%19.71M
Intangible assets 65.24%156.56M2.69%98.34M-1.98%99.69M-1.93%100.87M-8.89%94.75M-1.97%95.77M21.99%101.71M22.79%102.86M23.31%104M15.04%97.69M
Development expenditure 19.27%503M27.56%530.41M30.27%469.28M30.34%446.36M37.49%421.72M34.64%415.81M28.69%360.23M29.08%342.45M20.28%306.73M31.66%308.84M
Long deferred expense -13.21%31.84M-12.79%33.05M-12.39%34.26M-12.37%35.47M15.47%36.68M14.19%37.89M13.02%39.1M12.40%40.48M41.74%31.77M44.90%33.18M
Deferred tax assets 2.81%24.38M-0.48%25.73M-13.47%26.05M-15.07%28.92M-22.01%23.72M-9.90%25.85M1.95%30.1M19.78%34.05M11.04%30.41M6.65%28.69M
Usufruct assets -11.40%8.97M-27.58%7.89M-28.95%8.49M-20.53%9.34M-22.84%10.12M-18.43%10.9M--11.95M--11.75M--13.12M-17.89%13.36M
Other non current assets 189.66%10.72M227.15%13.2M15.39%10.8M30.25%5.25M-13.78%3.7M-7.65%4.04M21.08%9.36M-26.60%4.03M-23.57%4.29M-31.59%4.37M
Total non current assets 8.17%1.36B4.79%1.34B3.54%1.29B2.09%1.28B2.64%1.26B3.12%1.28B4.62%1.25B4.90%1.25B3.81%1.23B5.11%1.24B
Total assets 10.27%3.69B3.21%3.52B-3.88%3.44B-12.35%3.23B-9.11%3.34B-8.33%3.41B-2.33%3.58B3.66%3.69B-4.17%3.68B-2.60%3.72B
Liabilities
Current liabilities
Short term loan 86.59%84.03M153.18%114.02M-3.30%29.01M--59.04M--45.03M--45.03M--30M------------
Notes payable and accounts payable 24.43%45.53M-2.01%38.29M17.79%60.22M-56.63%34.41M-59.01%36.59M-40.54%39.08M-4.23%51.13M27.31%79.34M5.17%89.26M-31.03%65.72M
-Notes payable ----------30M----------------------------
-Accounts payable 24.43%45.53M-2.01%38.29M-40.89%30.22M-56.63%34.41M-59.01%36.59M-40.54%39.08M-4.23%51.13M27.31%79.34M5.17%89.26M-31.03%65.72M
Contract liabilities 194.82%28.54M29.95%13.8M45.12%11.94M-34.85%10.32M-30.90%9.68M-30.39%10.62M-69.89%8.23M21.00%15.84M16.15%14.01M-51.07%15.26M
Advance receipts 77.76%473.14K95.05%2.08M--374.21K--356K--266.17K--1.06M----------------
Salaries payable -30.70%10.71M-16.51%34.58M-19.20%15.15M4.99%15.7M-0.35%15.45M-6.84%41.42M-33.25%18.75M-35.96%14.96M-25.42%15.5M-21.43%44.46M
Taxs payable 8.62%13.94M-8.28%13.54M-31.48%21.16M-58.45%15.91M-67.76%12.84M-72.06%14.76M-37.35%30.88M-34.39%38.29M-31.81%39.81M-28.61%52.83M
Other payable (including interest and dividends) 104.45%380.48M26.12%210.53M112.22%369.11M-9.40%161.35M7.23%186.1M-23.73%166.93M-7.18%173.93M-14.33%178.1M-49.64%173.55M-46.47%218.85M
-Dividend payable ------------------------------25.65M--------
-Other payable ------------5.84%161.35M-----23.73%166.93M-----26.67%152.44M-----46.47%218.85M
Non current liabilities due within one year -0.33%3.56M-12.31%3.03M3.21%3.2M17.30%3.45M53.03%3.57M32.44%3.45M--3.1M--2.94M--2.34M3.37%2.61M
Other current liabilities 194.82%3.71M21.48%1.68M45.12%1.55M-55.40%918.13K-30.90%1.26M-30.39%1.38M-69.89%1.07M21.00%2.06M-31.63%1.82M-51.07%1.98M
Total current liabilities 83.72%570.97M33.30%431.55M61.38%511.72M-9.07%301.45M-7.58%310.78M-19.41%323.74M-9.15%317.09M-9.60%331.52M-38.11%336.29M-41.99%401.71M
Current liabilities
Deferred tax liabilities -18.95%10.18M-18.95%10.18M-16.73%12.56M-12.61%12.9M-16.73%12.56M-16.73%12.56M-4.14%15.08M-3.60%14.76M-2.63%15.08M-2.65%15.08M
Long term deferred income -5.46%63.73M15.97%64.72M30.25%68.6M16.94%70.54M-1.31%67.41M-19.04%55.81M-23.80%52.67M-13.78%60.32M-2.16%68.31M-0.69%68.93M
Lease liabilities -21.95%5.92M-24.27%6.75M-38.52%5.9M-19.88%7.94M-33.54%7.59M-22.59%8.92M--9.59M--9.91M--11.42M-16.19%11.52M
Total non current liabilities -8.83%79.83M5.65%81.65M12.56%87.06M7.52%91.39M-7.65%87.56M-19.10%77.29M-8.85%77.34M-0.33%85M11.14%94.81M-3.16%95.53M
Total liabilities 63.38%650.8M27.97%513.2M51.81%598.78M-5.69%392.83M-7.60%398.34M-19.35%401.03M-9.09%394.43M-7.85%416.52M-31.43%431.1M-37.15%497.24M
Shareholders equity
Paid-in capital 0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M0.00%928.16M
Capital reserve funds 165.50%117.45M169.95%136.94M9.83%62.73M-32.81%40.55M1,742.59%44.24M5,294.75%50.73M3,699.98%57.11M3,944.22%60.35M60.89%2.4M-36.99%940.31K
Surplus reserve funds 0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M0.00%248.23M
Retained profit -2.92%1.61B-8.59%1.58B-18.14%1.54B-20.17%1.57B-19.67%1.66B-15.56%1.73B-8.41%1.89B1.89%1.97B1.74%2.07B10.48%2.05B
Other composite income -67.61%3.51M-23.30%4.96M43.33%16.6M169.29%11.64M348.17%10.84M204.97%6.47M349.44%11.58M192.04%4.32M-8.04%-4.37M-66.38%-6.16M
Specific reserves 37.90%2.09M107.16%1.62M78.54%1.91M231.15%1.74M1,621.08%1.51M196.54%781.85K3.07%1.07M69.21%526.33K--88.02K--263.66K
Shareholders equity without minority interests 0.62%2.91B-2.13%2.9B-10.56%2.8B-12.72%2.8B-10.74%2.89B-7.94%2.96B-3.13%3.13B3.37%3.21B1.13%3.24B6.33%3.22B
Minority interests 140.96%124.62M119.77%110.7M-22.86%42.72M-37.30%40.19M759.16%51.72M470.78%50.37M24,301.31%55.38M2,200.24%64.1M35.27%6.02M45.70%8.82M
Total shareholder equity 3.09%3.04B-0.09%3.01B-10.77%2.84B-13.20%2.84B-9.31%2.94B-6.64%3.01B-1.43%3.19B5.34%3.27B1.17%3.25B6.41%3.23B
Total liabilityies and equity 10.27%3.69B3.21%3.52B-3.88%3.44B-12.35%3.23B-9.11%3.34B-8.33%3.41B-2.33%3.58B3.66%3.69B-4.17%3.68B-2.60%3.72B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg